- Home
- YMAB vs CCSI Comparison
YMAB vs CCSI Comparison
Compare YMAB & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- CCSI
- Stock Information
- Founded
- YMAB 2015
- CCSI 2021
- Country
- YMAB United States
- CCSI United States
- Employees
- YMAB N/A
- CCSI N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- CCSI Retail: Computer Software & Peripheral Equipment
- Sector
- YMAB Health Care
- CCSI Technology
- Exchange
- YMAB Nasdaq
- CCSI Nasdaq
- Market Cap
- YMAB 386.7M
- CCSI 450.6M
- IPO Year
- YMAB 2018
- CCSI N/A
- Fundamental
- Price
- YMAB $8.57
- CCSI $26.40
- Analyst Decision
- YMAB Buy
- CCSI Hold
- Analyst Count
- YMAB 10
- CCSI 5
- Target Price
- YMAB $13.91
- CCSI $27.20
- AVG Volume (30 Days)
- YMAB 2.2M
- CCSI 159.7K
- Earning Date
- YMAB 08-08-2025
- CCSI 08-07-2025
- Dividend Yield
- YMAB N/A
- CCSI N/A
- EPS Growth
- YMAB N/A
- CCSI N/A
- EPS
- YMAB N/A
- CCSI 4.15
- Revenue
- YMAB $85,385,000.00
- CCSI $349,595,000.00
- Revenue This Year
- YMAB N/A
- CCSI $1.55
- Revenue Next Year
- YMAB $13.97
- CCSI $1.10
- P/E Ratio
- YMAB N/A
- CCSI $6.40
- Revenue Growth
- YMAB N/A
- CCSI N/A
- 52 Week Low
- YMAB $3.55
- CCSI $17.84
- 52 Week High
- YMAB $16.11
- CCSI $32.10
- Technical
- Relative Strength Index (RSI)
- YMAB 81.31
- CCSI 62.68
- Support Level
- YMAB $8.50
- CCSI $26.16
- Resistance Level
- YMAB $8.56
- CCSI $27.15
- Average True Range (ATR)
- YMAB 0.02
- CCSI 0.72
- MACD
- YMAB -0.12
- CCSI -0.01
- Stochastic Oscillator
- YMAB 83.33
- CCSI 66.89
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.